BridgeMD
New treatment option for Upper Limb Sensorimotor Deficits
Official title Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation with Different Levels of Supervision
ClinicalTrials.gov ID: NCT06725784
What this study is testing
- What it's testing
- Upper limb impairments are often a result of neurological or traumatic injuries (e.g., stroke, traumatic brain injuries). These impairments may decrease independence in performing activities of daily living, severely affecting patients' quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Informed Consent signed by the subject.
- Female and male patients between 18 and 90 years old
- Presence of an upper limb deficit derived from any disease or event that, according to the responsible clinicians, could be improved by therapy with...
You likely can't join if
- Pathologies that may interfere with the training with ReHandyBot.
The study team makes the final eligibility decision.
Where it's taking place
- Brissago, Switzerland
- Lugano, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brissago, Switzerland; Lugano, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.